看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
4 v/ Z. T3 F7 {2 b" K3 {2 `
. f' e' G( O$ X2 }: P
. C9 z: c. O! l* I. [Currently available feasibility data for possible combination strategies.
" D. o% @. k5 F$ Q————————————————————————————————( f5 Z2 E$ c. r; O Y& `+ j9 Z& ~
Combination Feasibility according to preliminary data
& B" v1 P; Z8 k, i# h——————————————————————————————————' h4 y6 X6 j8 \8 G" E
Bevacizumab + sorafenib Yes, reduced dose 0 q' O# [9 H7 V ^9 x
Bevacizumab + sunitinib† No . X. s+ e( ^2 h
Bevacizumab + temsirolimus Yes
7 q. a9 v( U0 ~! P+ ^+ [1 ?; C# @* rBevacizumab + everolimus Yes
" {; m, s" I2 a1 h K& `* NSorafenib + sunitinib ? % H9 I! u, w0 v( g, ?
Sorafenib + temsirolimus Yes, reduced dose
9 }/ S5 Q3 K$ m/ |& n! P3 ESorafenib + everolimus Yes, reduced dose 1 o" M# d1 f2 n5 Y2 |% G2 Z
Sunitinib + temsirolimus† No ' g# A8 ]# e7 W
Sunitinib + everolimus ?
& n; U& y) z* G: E7 y BTemsirolimus + everolimus ?
; }# I5 B5 r. {8 a5 Z4 G! m# c————————————————————
( c4 q: D: L% }8 J3 `†Led to US FDA warning.
8 l5 ~7 I# l, _( |5 A; e2 h?: As yet unattempted combination.
7 `+ I) k3 s* @2 v, L |